Diffusivity and distribution of vinblastine in three-dimensional tumour tissue

Experimental and mathematical modelling

S. Modok, Philip Hyde, Howard R. Mellor, Tiina Roose, Richard Callaghan

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The distribution of chemotherapeutics in solid tumours is poorly understood and the contribution it makes to treatment failure is unknown. Novel approaches are required to understand how the three-dimensional organisation of cancer cells in solid tumours affects drug availability. Since convective drug transport is limited by increased interstitial pressure in poorly vascularised cancers, the aim of this study was to measure the diffusive hindrance exerted by solid tumour tissue. Multicell layer tumour models comprising DLD1 colon cancer cells were characterised and fluxes were determined for [3H]-vinblastine and [14C]-sucrose. The mathematical models provided the diffusion coefficients for both compounds and predicted higher exposure of cells in the vicinity of vessels. The diffusion of vinblastine was three times slower than that of sucrose. Although slow diffusion delays vinblastine penetration into the avascular regions of tumours, the proliferating cells are generally in the marginal area of tumours. The mathematical model that we have developed enabled accurate quantification of drug pharmacokinetic behaviour, in particular, the diffusivity of vinblastine within solid tissue. This mathematical model may be adapted readily to incorporate the influence of factors mediating pharmacokinetic drug resistance.

Original languageEnglish
Pages (from-to)2404-2413
Number of pages10
JournalEuropean Journal of Cancer
Volume42
Issue number14
DOIs
Publication statusPublished - Sep 2006

Fingerprint

Vinblastine
Neoplasms
Theoretical Models
Sucrose
Pharmacokinetics
Pharmaceutical Preparations
Treatment Failure
Drug Resistance
Colonic Neoplasms
Pressure

Keywords

  • 3-D tumour model
  • Colon cancer
  • Diffusion
  • Mathematical modelling
  • Multicell layer
  • Multicellular resistance
  • Vinblastine

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Diffusivity and distribution of vinblastine in three-dimensional tumour tissue : Experimental and mathematical modelling. / Modok, S.; Hyde, Philip; Mellor, Howard R.; Roose, Tiina; Callaghan, Richard.

In: European Journal of Cancer, Vol. 42, No. 14, 09.2006, p. 2404-2413.

Research output: Contribution to journalArticle

Modok, S. ; Hyde, Philip ; Mellor, Howard R. ; Roose, Tiina ; Callaghan, Richard. / Diffusivity and distribution of vinblastine in three-dimensional tumour tissue : Experimental and mathematical modelling. In: European Journal of Cancer. 2006 ; Vol. 42, No. 14. pp. 2404-2413.
@article{48a3e6d6f070487baaeb4bf82a0095d5,
title = "Diffusivity and distribution of vinblastine in three-dimensional tumour tissue: Experimental and mathematical modelling",
abstract = "The distribution of chemotherapeutics in solid tumours is poorly understood and the contribution it makes to treatment failure is unknown. Novel approaches are required to understand how the three-dimensional organisation of cancer cells in solid tumours affects drug availability. Since convective drug transport is limited by increased interstitial pressure in poorly vascularised cancers, the aim of this study was to measure the diffusive hindrance exerted by solid tumour tissue. Multicell layer tumour models comprising DLD1 colon cancer cells were characterised and fluxes were determined for [3H]-vinblastine and [14C]-sucrose. The mathematical models provided the diffusion coefficients for both compounds and predicted higher exposure of cells in the vicinity of vessels. The diffusion of vinblastine was three times slower than that of sucrose. Although slow diffusion delays vinblastine penetration into the avascular regions of tumours, the proliferating cells are generally in the marginal area of tumours. The mathematical model that we have developed enabled accurate quantification of drug pharmacokinetic behaviour, in particular, the diffusivity of vinblastine within solid tissue. This mathematical model may be adapted readily to incorporate the influence of factors mediating pharmacokinetic drug resistance.",
keywords = "3-D tumour model, Colon cancer, Diffusion, Mathematical modelling, Multicell layer, Multicellular resistance, Vinblastine",
author = "S. Modok and Philip Hyde and Mellor, {Howard R.} and Tiina Roose and Richard Callaghan",
year = "2006",
month = "9",
doi = "10.1016/j.ejca.2006.05.020",
language = "English",
volume = "42",
pages = "2404--2413",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "14",

}

TY - JOUR

T1 - Diffusivity and distribution of vinblastine in three-dimensional tumour tissue

T2 - Experimental and mathematical modelling

AU - Modok, S.

AU - Hyde, Philip

AU - Mellor, Howard R.

AU - Roose, Tiina

AU - Callaghan, Richard

PY - 2006/9

Y1 - 2006/9

N2 - The distribution of chemotherapeutics in solid tumours is poorly understood and the contribution it makes to treatment failure is unknown. Novel approaches are required to understand how the three-dimensional organisation of cancer cells in solid tumours affects drug availability. Since convective drug transport is limited by increased interstitial pressure in poorly vascularised cancers, the aim of this study was to measure the diffusive hindrance exerted by solid tumour tissue. Multicell layer tumour models comprising DLD1 colon cancer cells were characterised and fluxes were determined for [3H]-vinblastine and [14C]-sucrose. The mathematical models provided the diffusion coefficients for both compounds and predicted higher exposure of cells in the vicinity of vessels. The diffusion of vinblastine was three times slower than that of sucrose. Although slow diffusion delays vinblastine penetration into the avascular regions of tumours, the proliferating cells are generally in the marginal area of tumours. The mathematical model that we have developed enabled accurate quantification of drug pharmacokinetic behaviour, in particular, the diffusivity of vinblastine within solid tissue. This mathematical model may be adapted readily to incorporate the influence of factors mediating pharmacokinetic drug resistance.

AB - The distribution of chemotherapeutics in solid tumours is poorly understood and the contribution it makes to treatment failure is unknown. Novel approaches are required to understand how the three-dimensional organisation of cancer cells in solid tumours affects drug availability. Since convective drug transport is limited by increased interstitial pressure in poorly vascularised cancers, the aim of this study was to measure the diffusive hindrance exerted by solid tumour tissue. Multicell layer tumour models comprising DLD1 colon cancer cells were characterised and fluxes were determined for [3H]-vinblastine and [14C]-sucrose. The mathematical models provided the diffusion coefficients for both compounds and predicted higher exposure of cells in the vicinity of vessels. The diffusion of vinblastine was three times slower than that of sucrose. Although slow diffusion delays vinblastine penetration into the avascular regions of tumours, the proliferating cells are generally in the marginal area of tumours. The mathematical model that we have developed enabled accurate quantification of drug pharmacokinetic behaviour, in particular, the diffusivity of vinblastine within solid tissue. This mathematical model may be adapted readily to incorporate the influence of factors mediating pharmacokinetic drug resistance.

KW - 3-D tumour model

KW - Colon cancer

KW - Diffusion

KW - Mathematical modelling

KW - Multicell layer

KW - Multicellular resistance

KW - Vinblastine

UR - http://www.scopus.com/inward/record.url?scp=33748261839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748261839&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2006.05.020

DO - 10.1016/j.ejca.2006.05.020

M3 - Article

VL - 42

SP - 2404

EP - 2413

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 14

ER -